The effects of HIV-1 Tat on the barrier function of the RPE may be mediated by ERK MAPK and NF-κB activation, which may represent potential targets for novel therapeutic approaches for the retinopathy induced by HIV infection. The gene discussed is NFKB1; the disease is HIV infectious disease.